To connect emerging brands with a group of investors who can support their fundraising efforts, the BevNET & NOSH Virtually Live Summer 2020 two-day event will feature structured investor speed dating sessions to spark new business partnerships.
Though the current market has been thoroughly disrupted by the COVID-19 pandemic, leaving uncertainty about how consumer behavior will shift long term, a new report by market research firm IRI showed that last year was marked by numerous “blockbuster” food and beverage launches. Also, Euromonitor predicts food and beverage to be lone growth sector in 2020 as pandemic impacts become clearer.
Canopy’s initial beverage lineup reflects its strategy: in Tweed, Houseplant and the forthcoming Deep Space, Canopy is seeking to establish unique identities for each brand while generally being as inclusive as possible.
The fourteenth round of Elevator Talk Livestream features leaders from MALK, The GFB, Just Date and more. This week's special co-host is Larry Kahn of Beechwood Capital, who will share his thoughts, questions and feedback with the participants.
This week's Office Hours brings veteran investment bankers Jay Novak and Brandon Ng from Houlihan Lokey on the livestream to discuss the current fundraising and M&A market and take questions from viewers.
In response to the death of George Floyd, some of the country’s largest food and beverage companies, as well as a large group of entrepreneurs and emerging brands, have offered statements of support, financial donations to advocacy groups and commitments to open a dialogue about racial justice in America.
Justin Baldwin, founder of the acclaimed Justin Winery, chronicled the development of his highly awarded brand and spoke about the importance of leveraging one’s skill sets and admitting their weaknesses, mitigating risk through financial discipline and how entrepreneurs can best position their companies for success in good times and bad.
Shaka Tea, a Hawaii-based maker of ready-to-drink and bagged tea products, has raised $2.3 million in a funding round led by farming company Mahi Pono, bringing the brand’s total financing to $4.1 million. The round also includes investments from King’s Hawaiian, Gingerbread Capital, LDR Ventures, Allison Rose Culinary Ventures and Park Bench Capital as well as several angel investors.
We’re embarking on a journey to give food and beverage company founders a look behind the branding curtain and share insights from a real-time case study...and we need one of you to join us.
Brands started gearing up for warmer weather this month, with a limited edition summer launch from DRY Botanical Bubbly, new lemonades from IZZE and cherry-flavored releases from Olipop and Ugly. Check out the gallery for notable May launches, including Rebbl’s new keto line and kombucha-infused sparkling water from Mother Kombucha.
Allison & Stephen Ellsworth, co-founders of prebiotic soda brand Poppi, spoke about lessons learned from their first year in business, the keys to winning investment on “Shark Tank,” how they navigated a brand overhaul and maintaining their independence while aligned with influential and experienced strategic partners.
As discussed in a recent interview with CEO Benjamin Witte, Recess is expanding its line of CBD enhanced sparkling beverages to include flavors that target a mainstream audience. Today we’re taking a look at the three latest SKUs: Black Cherry, Blood Orange and Coconut Lime.
Office Hours returns Tuesday, June 2 at 3 p.m. ET. Jeff Klineman, BevNET’s Editor-in-Chief, will bring veteran investment bankers Jay Novak and Brandon Ng from Houlihan Lokey on the livestream to discuss the current fundraising and M&A market and take questions from viewers.
While both the CBD and cannabis industries have attracted increased attention from consumers, investors and retailers alike, brands within these categories still face a range of unique operational challenges. Jeremy Goldstein, the COO and co-founder of both CBD brand Caliper Foods and Cannabis company Stillwater Brands, sees the potential for massive growth if the FDA “gets off its hands.”
